Preventive Effect of S‐Allylcysteine on Membrane‐Bound Enzymes and Glycoproteins in Normal and Isoproterenol‐Induced Cardiac Toxicity in Male Wistar Rats
Open Access
- 11 November 2008
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 103 (6) , 507-513
Abstract
Abstract: This study was aimed to evaluate the preventive role of S‐allylcysteine (SAC) on creatine kinase‐MB, iron, iron binding capacity, uric acid, total protein, membrane‐bound enzymes such as sodium potassium‐dependent adenosine triphosphatase, calcium‐dependent adenosine triphosphatase and magnesium‐dependent adenosine triphosphatase, and glycoproteins such as hexose, hexosamine, fucose and sialic acid in isoproterenol‐induced myocardial infarction in rats. Male albino Wistar rats were pre‐treated with SAC (50, 100 and 150 mg/kg) daily for a period of 45 days. After the treatment period, isoproterenol (150 mg/kg) was subcutaneously injected in rats at an interval of 24 hr for 2 days. Isoproterenol‐induced rats showed significantly (P < 0.05) increased activities of serum creatine kinase‐MB and calcium‐dependent adenosine triphosphatase and magnesium‐dependent adenosine triphosphatase in the heart, and the levels of iron and uric acid in serum and significantly (P < 0.05) decreased the levels of plasma iron binding capacity, plasma total protein, plasma albumin/globulin ratio and activity of sodium potassium‐dependent adenosine triphosphatase in the heart. Isoproterenol induction also showed a significant increase in the levels of glycoproteins in serum and the heart. Pre‐treatment with SAC (100 and 150 mg/kg) daily for a period of 45 days exhibited significant (P < 0.05) effect and altered these biochemical parameters positively. SAC (50, 100 and 150 mg/kg) treatment to normal rats did not exhibit any significant effect in any of the parameters studied. Thus, our study shows that SAC has a protective role in isoproterenol‐induced myocardial infarction in rats. The observed effects might be due to the free radical scavenging, antioxidant and membrane stabilizing properties of SAC.Keywords
This publication has 33 references indexed in Scilit:
- S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymesLife Sciences, 2007
- Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: A histopathological studyToxicology, 2006
- Effects of pharmacological amounts of S‐allylcysteine on lipids in normal and isoproterenol‐induced myocardial infarction in ratsJournal of the Science of Food and Agriculture, 2006
- Mechanisms of Cardioprotective Effect of Withania somnifera in Experimentally Induced Myocardial InfarctionBasic & Clinical Pharmacology & Toxicology, 2004
- Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events After Acute StrokeStroke, 2003
- Effects of Oxodipine and Nitrendipine on the Size of Experimental Myocardial Infarct in the RatBasic & Clinical Pharmacology & Toxicology, 1994
- Serum Sialic Acid, a Risk Factor for Cardiovascular Disease, Is Increased in IDDM Patients With Microalbuminuria and Clinical ProteinuriaDiabetes Care, 1994
- Sialic acid and cardiovascular mortality.BMJ, 1991
- Erythrocyte defects precede the onset of CCl4-induced liver cirrhosis. Protection by silymarinLife Sciences, 1991
- Myocardial infarction in young vs old male rats: Pathophysiologic changesAmerican Heart Journal, 1978